Opaleye Management Inc. Quant / Systematic

Location: Boston, MA

CIK: 0001595855 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 14, 2019

Total Value: $268M (100.0% shares, 0.0% debt)

Holdings (47)

CDXS CODEXIS INC 10.9%
Value $29.23M Shares 1,750,000 Est. Cost $3.21 Unrealized +437.5%
AXGN AXOGEN INC 9.9%
Value $26.56M Shares 1,300,000 Est. Cost $3.33 Unrealized +840.6%
LOXO ONCOLOGY INC 9.1%
Value $24.51M Shares 175,000 Est. Cost $43.63 Unrealized
AMARIN CORP PLC 6.3%
Value $17.01M Shares 1,250,000 Est. Cost $3.50 Unrealized
BLUEPRINT MEDICINES CORP 6.0%
Value $16.17M Shares 300,000 Est. Cost $27.77 Unrealized
IMPRIMIS PHARMACEUTICALS INC 3.7%
Value $9.798M Shares 1,722,000 Est. Cost $2.95 Unrealized
FIBROGEN INC 3.5%
Value $9.256M Shares 200,000 Est. Cost $26.18 Unrealized
DECIPHERA PHARMACEUTICALS IN 2.7%
Value $7.136M Shares 340,000 Est. Cost $22.57 Unrealized
EPIZYME INC 2.6%
Value $6.93M Shares 1,125,000 Est. Cost $7.66 Unrealized
PTCT PTC THERAPEUTICS INC 2.4%
Value $6.52M Shares 190,000 Est. Cost $26.97 Unrealized +33.3%
XNCR XENCOR INC 2.4%
Value $6.508M Shares 180,000 Est. Cost $34.46 Unrealized +6.5%
VKTX VIKING THERAPEUTICS INC 2.4%
Value $6.311M Shares 825,000 Est. Cost $4.57 Unrealized +161.5%
STRONGBRIDGE BIOPHARMA PLC 2.3%
Value $6.227M Shares 1,390,000 Est. Cost $4.28 Unrealized
CERECOR INC 2.3%
Value $6.212M Shares 2,185,536 Est. Cost $2.84 Unrealized
FENC FENNEC PHARMACEUTICALS INC 2.1%
Value $5.742M Shares 900,000 Est. Cost $10.08 Unrealized -30.7%
SGMO SANGAMO BIOSCIENCES INC 2.1%
Value $5.74M Shares 500,000 Est. Cost $3.93 Unrealized +216.1%
CYMABAY THERAPEUTICS INC 2.1%
Value $5.705M Shares 725,000 Est. Cost $8.29 Unrealized
POLARITYTE INC 2.0%
Value $5.396M Shares 400,000 Est. Cost $23.54 Unrealized
AUDENTES THERAPEUTICS INC 2.0%
Value $5.33M Shares 250,000 Est. Cost $24.54 Unrealized
CHIMERIX INC 1.9%
Value $5.191M Shares 2,020,000 Est. Cost $3.93 Unrealized
XOMA XOMA CORP DEL 1.9%
Value $5.06M Shares 400,000 Est. Cost $8.03 Unrealized +78.2%
IMMUNOGEN INC 1.8%
Value $4.9M Shares 1,021,000 Est. Cost $4.80 Unrealized
APLS APELLIS PHARMACEUTICALS INC 1.4%
Value $3.627M Shares 275,000 Est. Cost $21.66 Unrealized -29.2%
AIMMUNE THERAPEUTICS INC 1.3%
Value $3.588M Shares 150,000 Est. Cost $23.92 Unrealized
ABEONA THERAPEUTICS INC 1.2%
Value $3.213M Shares 450,000 Est. Cost $7.14 Unrealized
ETON ETON PHARMACEUTICALS INC 1.2%
Value $3.2M Shares 523,000 Est. Cost $6.13 Unrealized 0.0%
ACAD ACADIA PHARMACEUTICALS INC 1.2%
Value $3.153M Shares 195,000 Est. Cost $15.73 Unrealized +23.4%
TRICIDA INC 1.1%
Value $2.9M Shares 123,000 Est. Cost $26.47 Unrealized
MAGENTA THERAPEUTICS INC 1.1%
Value $2.878M Shares 505,000 Est. Cost $13.14 Unrealized
CIDARA THERAPEUTICS INC 1.1%
Value $2.82M Shares 1,200,000 Est. Cost $5.20 Unrealized
AVENUE THERAPEUTICS INC 1.0%
Value $2.678M Shares 496,000 Est. Cost $5.40 Unrealized
TGTX TG THERAPEUTICS INC 0.8%
Value $2.255M Shares 550,000 Est. Cost $10.29 Unrealized -51.7%
PBYI PUMA BIOTECHNOLOGY INC 0.8%
Value $2.035M Shares 100,000 Est. Cost $30.01 Unrealized 0.0%
EIDOS THERAPEUTICS INC 0.7%
Value $1.926M Shares 140,000 Est. Cost $13.76 Unrealized
MGNX MACROGENICS INC 0.7%
Value $1.905M Shares 150,000 Est. Cost $16.77 Unrealized 0.0%
CLEMENTIA PHARMACEUTICALS INC 0.7%
Value $1.764M Shares 150,000 Est. Cost $11.15 Unrealized
ZYMEWORKS INC 0.6%
Value $1.541M Shares 105,000 Est. Cost $14.68 Unrealized
COLL COLLEGIUM PHARMACEUTICALS INC 0.5%
Value $1.373M Shares 80,000 Est. Cost $17.11 Unrealized 0.0%
MIRAGEN THERAPEUTICS INC 0.4%
Value $1.166M Shares 385,000 Est. Cost $6.29 Unrealized
CTI BIOPHARMA CORP 0.4%
Value $1.027M Shares 1,400,000 Est. Cost $2.45 Unrealized
PROTALIX BIOTHERAPEUTICS INC 0.3%
Value $777K Shares 2,500,000 Est. Cost $0.61 Unrealized
ODONATE THERAPEUTICS INC 0.3%
Value $690K Shares 49,000 Est. Cost $14.08 Unrealized
AXOVANT SCIENCES 0.2%
Value $577K Shares 580,000 Est. Cost $0.99 Unrealized
DERMIRA INC 0.2%
Value $539K Shares 75,000 Est. Cost $10.89 Unrealized
ASSERTIO THERAPEUTICS INC 0.2%
Value $433K Shares 120,000 Est. Cost $3.61 Unrealized
ARDELYX INC 0.1%
Value $358K Shares 200,000 Est. Cost $5.56 Unrealized
BIOLINERX LTD 0.0%
Value $109K Shares 250,000 Est. Cost $1426.15 Unrealized